Stocktoria
Cosmos Health Inc. COSM
Nasdaq · stock · Wholesale-Drugs, Proprietaries & Druggists' Sundries · website · IPO 2010-05-19 · LEI
Cosmos Health Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $65.3M | $54.4M | $53.4M | $50.3M | $56.2M | $55.4M | $39.7M | $37.1M | $30.0M | $6.8M |
| Gross profit | $7.9M | $4.3M | $4.3M | $6.0M | $8.3M | $8.1M | $3.7M | $2.4M | $2.0M | $601,040 |
| R&D expense | $519,363 | $533,293 | $164,859 | — | — | — | — | — | — | — |
| Operating income | -$16.7M | -$15.5M | -$21.8M | -$7.5M | -$4.5M | $2.7M | -$255,809 | -$1.2M | -$4.9M | -$202,507 |
| Interest expense | $1.9M | $1.0M | $866,476 | $2.3M | $2.8M | $2.8M | -$1.4M | -$967,824 | $748,474 | $189,687 |
| Income tax | $0 | $0 | $0 | -$775,051 | $114,010 | -$377,535 | $182,815 | -$17,326 | $2,801 | $769 |
| Net income | -$19.1M | -$16.2M | -$18.5M | -$13.8M | -$8.0M | $820,786 | -$3.3M | -$9.1M | -$6.2M | -$601,002 |
| EPS (diluted) | $-0.63 | $-1.17 | $-2.15 | $-33.16 | $-23.74 | $0.06 | $-0.25 | $-0.68 | $-0.49 | $80741.00 |
| Operating cash flow | -$8.4M | -$7.7M | -$15.6M | -$14.9M | -$7.1M | -$11.5M | -$4.8M | -$1.6M | -$8.8M | -$2.1M |
| Free cash flow | -$8.5M | -$8.1M | -$16.9M | -$14.9M | -$7.7M | -$11.6M | — | -$2.1M | -$8.8M | -$2.1M |
| Cash & equivalents | $715,674 | $315,105 | — | $20.7M | $286,487 | $628,395 | $38,537 | $864,343 | $782,853 | $716,590 |
| Inventory | $5.8M | $4.4M | $4.8M | $3.5M | $3.1M | $3.3M | $3.5M | $3.2M | — | — |
| Total assets | $65.5M | $54.3M | $66.0M | $68.0M | $49.4M | $43.8M | $23.9M | $20.7M | $10.7M | $3.1M |
| Total liabilities | $47.1M | $29.8M | $30.0M | $28.4M | $45.0M | $48.0M | $30.3M | $24.0M | $13.7M | $4.9M |
| Shareholders' equity | $18.4M | $24.5M | $36.0M | $39.3M | $4.4M | -$4.2M | -$6.5M | -$3.3M | -$3.0M | -$1.8M |
Growth · year-over-year · Revenue CAGR 28.7%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +19.9% | +2.0% | +6.0% | -10.5% | +1.5% | +39.6% | +7.0% | +23.6% | +344.3% | +1165.5% |
| Net income growth | — | — | — | — | -1070.0% | — | — | — | — | — |
| EPS growth | — | — | — | — | -39666.7% | — | — | — | -100.0% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.